Check J H, Nowroozi K, Chase J S, Nazari A, Shapse D, Vaze M
University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Camden.
Fertil Steril. 1990 May;53(5):811-6. doi: 10.1016/s0015-0282(16)53514-6.
The efficacy of a technique of gonadotropin suppression and human menopausal gonadotropins (hMG) to induce ovulation in women with hypergonadotropic amenorrhea was evaluated in 100 consecutive women. Ovulation was achieved in 19% of cycles (68/361), the pregnancy rate per cycle was 5.2% (19/361), and the viable pregnancy rate was 2.2% (8/361). In the majority of the successful cases, estrogen was used to decrease the elevated luteinizing hormone and follicle-stimulating hormone levels, especially where the ethinyl estradiol therapy alone induced a rise in endogenous 17 beta-estradiol levels with hMG used to boost the follicle to maturation. Although the success rate is low, this technique can result in some successes in otherwise almost hopeless cases.
在100例连续的高促性腺激素性闭经女性中,评估了促性腺激素抑制技术联合人绝经期促性腺激素(hMG)诱导排卵的疗效。19%的周期(68/361)实现了排卵,每个周期的妊娠率为5.2%(19/361),活产妊娠率为2.2%(8/361)。在大多数成功案例中,使用雌激素来降低升高的黄体生成素和卵泡刺激素水平,特别是在单独使用乙炔雌二醇治疗导致内源性17β-雌二醇水平升高且使用hMG促进卵泡成熟的情况下。尽管成功率较低,但该技术在其他几乎无望的病例中仍能取得一些成功。